Scienture Holdings, Inc. has entered into a securities purchase agreement with institutional investors to purchase 3,225,000 shares of common stock at an offering price of $1.20 per share.
The gross proceeds for the offering are expected to be approximately $3.9 million before deducting placement agent fees and other offering expenses.
The offering is expected to close on August 15, 2025, subject to customary closing conditions.
Securities Purchase Agreement
Entered into an agreement to sell 3,225,000 shares of common stock to institutional investors.
Offering Price
The offering price per share is $1.20, totaling approximate gross proceeds of $3.9 million.
Closing Date
The offering is set to close on August 15, 2025, pending customary closing conditions.
- The securities purchase agreement signifies a strategic move by Scienture Holdings, Inc. to raise capital through institutional investors.
- The successful completion of the offering will provide the company with financial resources for its pharmaceutical operations.
The securities purchase agreement marks a significant milestone for Scienture Holdings, Inc. as it continues to expand its presence in the pharmaceutical market through strategic financial initiatives.